152 related articles for article (PubMed ID: 9705413)
1. Use of laboratory assays to predict cytomegalovirus disease in renal transplant recipients.
Tong CY; Cuevas L; Williams H; Bakran A
J Clin Microbiol; 1998 Sep; 36(9):2681-5. PubMed ID: 9705413
[TBL] [Abstract][Full Text] [Related]
2. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the CMV antigenemia test and CMV-DNA PCR results in solid organ transplant recipients].
Özkarata E; Özbek ÖA; Avkan Oğuz V; Sayıner AA
Mikrobiyol Bul; 2016 Jan; 50(1):44-52. PubMed ID: 27058328
[TBL] [Abstract][Full Text] [Related]
4. The role of PCR in the diagnosis and management of CMV in solid organ recipients: what is the predictive value for the development of disease and should PCR be used to guide antiviral therapy?
Abecassis MM; Koffron AJ; Kaplan B; Buckingham M; Muldoon JP; Cribbins AJ; Kaufman DB; Fryer JP; Stuart J; Stuart FP
Transplantation; 1997 Jan; 63(2):275-9. PubMed ID: 9020330
[TBL] [Abstract][Full Text] [Related]
5. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients.
Wirgart BZ; Claesson K; Eriksson BM; Brundin M; Tufveson G; Tötterman T; Grillner L
Clin Diagn Virol; 1996 Nov; 7(2):99-110. PubMed ID: 9137866
[TBL] [Abstract][Full Text] [Related]
7. Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.
Solano C; Muñoz I; Gutiérrez A; Farga A; Prósper F; García-Conde J; Navarro D; Gimeno C
J Clin Microbiol; 2001 Nov; 39(11):3938-41. PubMed ID: 11682510
[TBL] [Abstract][Full Text] [Related]
8. Prediction and diagnosis of cytomegalovirus disease in renal transplant recipients using qualitative and quantitative polymerase chain reaction.
Tong CY; Cuevas LE; Williams H; Bakran A
Transplantation; 2000 Mar; 69(5):985-91. PubMed ID: 10755562
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the AmpliSensor PCR and the SHARP signal detection system for the early prediction of symptomatic CMV infection in solid transplant recipients.
Rautenberg P; Lübbert C; Weers W; Boetel E; Schweichler J; Zhou L; Costard-Jäckle A; Kraemer-Hansen H; Harder TC
J Clin Virol; 1999 Jun; 13(1-2):81-94. PubMed ID: 10405895
[TBL] [Abstract][Full Text] [Related]
10. Comparison of quantitative PCR and antigenemia in cytomegalovirus infection in renal transplant recipients.
Bordils A; Plumed JS; Ramos D; Beneyto I; Mascarós V; Molina JM; Cordoba J; García J; Crúz JM
Transplant Proc; 2005 Nov; 37(9):3756-9. PubMed ID: 16386529
[TBL] [Abstract][Full Text] [Related]
11. Definitions of cytomegalovirus disease after heart transplantation: antigenemia as a marker for antiviral therapy.
Iberer F; Tscheliessnigg K; Halwachs G; Rehak P; Wasler A; Petutschnigg B; Schreier G; Müller H; Allmayer T; Freigassner M; Prenner G; Hipmair G; Grasser B
Transpl Int; 1996; 9(3):236-42. PubMed ID: 8723193
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients.
Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lautenschlager I
J Clin Virol; 2004 Jul; 30(3):258-66. PubMed ID: 15135746
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of CMV infection after renal transplantation: serology, culture, and viral DNA detection by hybrid capture.
Flechner SM; Avery RK; Fisher R; Mastroianni B; Papajcik D; O'Malley KJ; Goormastic M; Goldfarb DA; Modlin CS; Novick AC
Transplant Proc; 1999; 31(1-2):1255-7. PubMed ID: 10083560
[No Abstract] [Full Text] [Related]
14. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Murex Hybrid Capture CMV DNA (v2.0) assay and the pp65 CMV antigenemia test for the detection and quantitation of CMV in blood samples from immunocompromised patients.
Schirm J; Kooistra A; van Son WJ; van der Bij W; Verschuuren E; Sprenger HG; Limburg PC; The TH
J Clin Virol; 1999 Dec; 14(3):153-65. PubMed ID: 10614852
[TBL] [Abstract][Full Text] [Related]
16. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of molecular techniques in prediction and diagnosis of cytomegalovirus disease in immunocompromised patients.
Szczepura A; Westmoreland D; Vinogradova Y; Fox J; Clark M
Health Technol Assess; 2006 Apr; 10(10):1-176. PubMed ID: 16595079
[TBL] [Abstract][Full Text] [Related]
18. Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture.
Boeckh M; Gallez-Hawkins GM; Myerson D; Zaia JA; Bowden RA
Transplantation; 1997 Jul; 64(1):108-13. PubMed ID: 9233710
[TBL] [Abstract][Full Text] [Related]
19. Does valganciclovir hydrochloride (valcyte) provide effective prophylaxis against cytomegalovirus infection in liver transplant recipients?
Jain A; Orloff M; Kashyap R; Lansing K; Betts R; Mohanka R; Menegus M; Ryan C; Bozorgzadeh A
Transplant Proc; 2005 Sep; 37(7):3182-6. PubMed ID: 16213344
[TBL] [Abstract][Full Text] [Related]
20. Differences between the quantitative antigenemia assay and the cobas amplicor monitor quantitative PCR assay for detecting CMV viraemia in bone marrow and solid organ transplant patients.
Flexman J; Kay I; Fonte R; Herrmann R; Gabbay E; Palladino S
J Med Virol; 2001 Jul; 64(3):275-82. PubMed ID: 11424115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
